Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
about
Management of herpes zoster ophthalmicus in people with HIV infectionHerpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspectiveAnimal models of varicella zoster virus infectionIncidence of Alpha-Herpes virus induced ocular disease in Suriname.Recurrent nontuberculous mycobacterial endophthalmitis: a diagnostic conundrum.Systematic review of incidence and complications of herpes zoster: towards a global perspective.Ocular involvement and visual outcome of herpes zoster ophthalmicus: review of 45 patients from Tunisia, North Africa.Herpes zoster (shingles) and postherpetic neuralgiaAbortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.Orbital apex syndrome: an unusual complication of herpes zoster ophthalmicus.Varicella zoster virus-associated anterior uveitis in a seronegative adult without a history of chickenpox.Diffusion tensor magnetic resonance imaging of trigeminal nerves in relapsing herpetic keratouveitis.Herpes zoster ophthalmicus and lateral rectus palsy in an elderly patientCorneal Reinnervation and Sensation Recovery in Patients With Herpes Zoster Ophthalmicus: An In Vivo and Ex Vivo Study of Corneal NervesInitial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study.Orbital apex syndrome and meningoencephalitis: a rare complication of herpes zoster.Blindness resulting from orbital complications of ophthalmic zoster.The dominant human conjunctival epithelial CD8αβ+ T cell population is maintained with age but the number of CD4+ T cells increases.Unilateral herpes zoster ophthalmicus results in bilateral corneal nerve alteration: an in vivo confocal microscopy study.Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.In Vivo confocal microscopic changes of the corneal epithelium and stroma in patients with herpes zoster ophthalmicus.Ophthalmic manifestations of herpes zoster virus in patients with multiple myeloma following bone marrow transplantation.Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and ChronicityPractice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus.Herpes zoster eye complications: rates and trendsDyscoria associated with herpesvirus infection in owl monkeys (Aotus nancymae).Eye and Periocular Skin Involvement in Herpes Zoster InfectionHerpes Zoster Ophthalmicus That Mimics the SUNCT Syndrome.Pathophysiological mechanisms of headache in patients with HIV.Ocular infections in sub-Saharan Africa in the context of high HIV prevalence.Coinfection with herpes zoster ophthalmicus and oriental eye worm in a rural woman: the first report of an unusual case.Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases.Persistent dilemmas in zoster eye disease.Herpes zoster ophthalmicus: declining age at presentation.Functional decline and herpes zoster in older people: an interplay of multiple factors.Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches.Herpes zoster and the search for an effective vaccine.European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment.Other facial neuralgias.Herpesvirus detection and cytokine levels (IL-10, IL-6, and IFN-γ) in ocular fluid from Tunisian immunocompetent patients with uveitis.
P2860
Q24234863-148807EB-5468-4FE9-8516-2038590FC2B4Q26781940-8F21C26C-FE75-43CF-8403-221643CB964DQ27011703-F2EECD38-D94B-419B-9665-C9CBE5F67BE7Q29353568-E80B6706-4067-4B6C-A0A9-916C0314DCD7Q33583529-0CC94579-B06F-4116-8F48-3B6768CF4DBEQ33795551-1AF77001-25AB-467D-9DC4-865B553A0D2FQ34212844-030BE29C-79FB-4564-A616-27EF2F1ACA58Q34954600-E50613E6-1C43-4ACA-8C8B-9488240BB59DQ34991446-738C7E82-1EBA-4FF5-B063-5647E185D684Q35041328-2567A12B-F4FB-4594-9744-FC57EEA7033EQ35142727-6FB056A2-2699-4E37-93BE-B6A0407F6C7EQ35242893-CC225520-14DE-4594-943A-9BB616FBC26AQ35574192-ABCA9D81-2EB3-4AD7-85FE-B120838EC992Q35962154-8F75DF11-66FD-4206-B509-4E5BA60AB424Q36155105-F13ED918-72F3-40BF-A029-B39CFC2392D9Q36183598-122B3706-2405-41CD-9146-462E4E981544Q36408478-0005C9A3-1F14-45FF-BC9E-D953411DDAE7Q36483107-D4760E67-AD83-47C7-92F2-8B72249F851AQ36619252-1C8EB0CB-EBF6-4BBD-BC9B-CF0B740EB640Q36674803-19598C04-1F80-448E-8047-58055C85CB8EQ36679476-B940C0B0-4264-4AA0-9B64-F15332A19F54Q36703679-67F81CA6-A3ED-4FF4-9B4C-7F84284ADB88Q37038580-D6456390-0A6F-4804-9F5F-301EFD22F753Q37058919-FF723A17-942C-41FD-82F2-EA6B2748EF08Q37211248-A9046E4D-ED60-4565-960A-95F3C6115AC4Q37223376-268E322D-5941-464B-B848-6F4382075D75Q37380047-26E19FE6-08D3-46D0-A9A3-55207B28202AQ37703730-63951DD2-7EFD-4372-8145-7662B0FEFE01Q38204789-66F5FD2B-6419-43C9-8FDA-E833D0561CE0Q38231302-01191CAA-B62F-4075-B6FF-F7CEDAB77580Q38302988-E0D7B98F-9BC2-4C17-858C-CAE6385AA78BQ38303228-F793894D-66AB-467F-AD3D-24EE4E3B4459Q38475791-DB1D76ED-10D9-45A2-A3EA-6837F1ED17FBQ38547930-B578CC72-898D-43DB-90ED-A58BF97F6DE3Q38600346-A1F1DC0A-98C4-4010-97A4-8B7A4B6D3183Q38766815-AD92EBD6-F110-45C8-AAC3-73BB83837F6EQ38831062-DC824DB3-D85E-467F-AE7F-5089A9CD6789Q38942259-D751C981-EBF8-4625-B2C0-23B7C9A3F6D8Q39108873-4AB3C2FD-4BDB-4398-98B2-D7C2CC40E34CQ39290857-82889DE8-3E8C-42BC-8B4D-74614E336F4F
P2860
Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@ast
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@en
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@nl
type
label
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@ast
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@en
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@nl
prefLabel
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@ast
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@en
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@nl
P1433
P1476
Herpes zoster ophthalmicus nat ...... l presentation, and morbidity.
@en
P2093
Thomas J Liesegang
P356
10.1016/J.OPHTHA.2007.10.009
P433
P577
2008-02-01T00:00:00Z